Tetrandrine family pharmaceutical formulations and method
US10023584B2 · kind B2 · utility
0Cited by
2References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 8, 2016 |
| Grant date | Jul 17, 2018 |
| Priority date | — |
| Expiry date | Nov 8, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.